155 related articles for article (PubMed ID: 35120263)
41. [Clinicopathologic features of parathyroid carcinoma: a study of 11 cases with review of literature].
Li J; Chen W; Liu A
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):296-300. PubMed ID: 25030860
[TBL] [Abstract][Full Text] [Related]
42. [Parathyroid carcinoma].
Filipović A; Paunović I; Savjak D; Zivković T
Vojnosanit Pregl; 2006 Aug; 63(8):765-9. PubMed ID: 16918165
[TBL] [Abstract][Full Text] [Related]
43. [Retrosternal parathyroid gland cystic neoplasm as a cause of primary hyperparathyroidism].
Barczyński M; Trznadel-Morawska I; Cichoń S; Barczyński M; Sieradzki J
Przegl Lek; 1999; 56(10):679-81. PubMed ID: 10695386
[TBL] [Abstract][Full Text] [Related]
44. [An update on parathyroid carcinoma].
Barberán M; Campusano C; Salman P; Trejo P; Silva-Figueroa A; Rivera S; Florenzano P; Velasco S; Illanes F; Trincado P; Canessa J; Solar A; Moreno M; Eugenin D; Jiménez B; Arroyo P
Rev Med Chil; 2021 Mar; 149(3):399-408. PubMed ID: 34479319
[TBL] [Abstract][Full Text] [Related]
45. Parathyroid carcinoma.
Rodgers SE; Perrier ND
Curr Opin Oncol; 2006 Jan; 18(1):16-22. PubMed ID: 16357559
[TBL] [Abstract][Full Text] [Related]
46. Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
Saponaro F; Pardi E; Mazoni L; Borsari S; Torregrossa L; Apicella M; Frustaci G; Materazzi G; Miccoli P; Basolo F; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4565-e4579. PubMed ID: 34157106
[TBL] [Abstract][Full Text] [Related]
47. Primary hyperparathyroidism. Our experience.
De Marinis L; Mancini A; Sciuto R; Calabrò F; Zuppi P; Fiumara C; Goglia A; Sofo L; Bellantone R; Crucitti F
Minerva Endocrinol; 1991; 16(3):107-11. PubMed ID: 1806807
[TBL] [Abstract][Full Text] [Related]
48. Parathyroid cancer: clinical variations and relationship to autotransplantation.
Rosen IB; Young JE; Archibald SD; Walfish PG; Vale J
Can J Surg; 1994 Dec; 37(6):465-9. PubMed ID: 7982149
[TBL] [Abstract][Full Text] [Related]
49. Parathyroid carcinoma.
Kebebew E
Curr Treat Options Oncol; 2001 Aug; 2(4):347-54. PubMed ID: 12057115
[TBL] [Abstract][Full Text] [Related]
50. Control of Refractory Hypercalcemia with Denosumab in a Case of Metastatic Parathyroid Carcinoma.
Çalapkulu M; Gul OO; Cander S; Ersoy C; Erturk E; Sagiroglu MF; Saraydaroglu O
J Coll Physicians Surg Pak; 2020 Jul; 30(7):757-759. PubMed ID: 32811610
[TBL] [Abstract][Full Text] [Related]
51. Immunoperoxidase confirmation of ultrasonically guided fine needle aspirates in patients with recurrent hyperparathyroidism.
Sardi A; Bolton JS; Mitchell WT; Merritt CR
Surg Gynecol Obstet; 1992 Dec; 175(6):563-8. PubMed ID: 1448738
[TBL] [Abstract][Full Text] [Related]
52. Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.
Roukain A; Alwan H; Bongiovanni M; Sykiotis GP; Kopp PA
Front Endocrinol (Lausanne); 2021; 12():794988. PubMed ID: 35173680
[TBL] [Abstract][Full Text] [Related]
53. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
54. Contemporary Evaluation and Management of Parathyroid Carcinoma.
Fingeret AL
JCO Oncol Pract; 2021 Jan; 17(1):17-21. PubMed ID: 32040373
[TBL] [Abstract][Full Text] [Related]
55. Is extensive surgery really necessary in patients with parathyroid carcinoma? Single-centre experience and a brief review of the literature.
Canu GL; Medas F; Cappellacci F; Piras S; Sorrenti S; Erdas E; Calò PG
Ann Ital Chir; 2021; 92():227-233. PubMed ID: 34312331
[TBL] [Abstract][Full Text] [Related]
56. Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review.
Di Meo G; Sgaramella LI; Ferraro V; Prete FP; Gurrado A; Testini M
Clin Exp Med; 2018 Nov; 18(4):585-593. PubMed ID: 29922966
[TBL] [Abstract][Full Text] [Related]
57. Parathyroid carcinoma: biochemical and pathologic response to DTIC.
Calandra DB; Chejfec G; Foy BK; Lawrence AM; Paloyan E
Surgery; 1984 Dec; 96(6):1132-7. PubMed ID: 6505966
[TBL] [Abstract][Full Text] [Related]
58. Parathyroid carcinoma: update and guidelines for management.
Wei CH; Harari A
Curr Treat Options Oncol; 2012 Mar; 13(1):11-23. PubMed ID: 22327883
[TBL] [Abstract][Full Text] [Related]
59. The many guises of primary hyperparathyroidism: An unchanged scenario.
Ahsan T; Erum U; Inam Pal KM; Jabeen R; Qureeshi SG; Rehman UL; Banu Z
J Pak Med Assoc; 2017 Apr; 67(4):580-585. PubMed ID: 28420920
[TBL] [Abstract][Full Text] [Related]
60. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.
Gurrado A; Marzullo A; Lissidini G; Lippolis A; Rubini D; Lastilla G; Testini M
World J Surg Oncol; 2008 Feb; 6():24. PubMed ID: 18291038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
